• intloko_ibhena_01

I-Semaglutide ye-Type 2 Diabetes

Inkcazelo emfutshane:

Igama: Semaglutide

Inombolo ye-CAS: 910463-68-2

Ifomula yemolekyuli: C187H291N45O59

Ubunzima bemolekyuli: 4113.57754

Inombolo ye-EINECS: 203-405-2


Iinkcukacha zeMveliso

Iithegi zeMveliso

Iinkcukacha zeMveliso

Igama Semaglutide
Inombolo yeCAS 910463-68-2
Ifomula yemolekyuli C187H291N45O59
Ubunzima bemolekyuli 4113.57754
Inombolo ye-EINECS 203-405-2

Izithethantonye

I-Sermaglutide; I-Semaglutide fandachem; ukungcola kweSemaglutide; I-Sermaglutide USP/EP; i-semaglutide; I-Sermaglutide CAS 910463 68 2; Ozempic,

Inkcazo

I-Semaglutide sisizukulwana esitsha se-GLP-1 (i-glucagon-like peptide-1) analogues, kwaye i-semaglutide yifom yedosi yexesha elide ephuhliswe ngokusekelwe kwisiseko esisisiseko se-liraglutide, enempembelelo engcono kunyango lwe-2 yeswekile. I-Novo Nordisk iye yagqiba izifundo ze-6 zeSigaba se-III se-semaglutide injection, kwaye yangenisa isicelo esitsha sokubhaliswa kweziyobisi kwi-semaglutide i-injection yeveki kwi-US Food and Drug Administration (FDA) ngoDisemba 5, 2016. Isicelo se-Marketing Authorization Application (MAA) nayo yathunyelwa kwi-European Medicines Agency (EMA).

Xa kuthelekiswa ne-liraglutide, i-semaglutide ine-aliphatic chain ende kunye nokunyuka kwe-hydrophobicity, kodwa i-semaglutide iguqulwa ngekhonkco elifutshane le-PEG, kwaye i-hydrophilicity yayo iphuculwe kakhulu. Emva kokuguqulwa kwe-PEG, ayikwazi nje ukubopha ngokusondeleyo kwi-albumin, igubungele indawo ye-enzymatic hydrolysis ye-DPP-4, kodwa iphinde inciphise ukukhutshwa kwezintso, ukwandisa ixesha le-biological half-life, kunye nokufezekisa umphumo wokujikeleza ixesha elide.

Isicelo

I-Semaglutide yindlela yokulinganisa ixesha elide eliphuhliswe ngokusekelwe kwisiseko esisisiseko se-liraglutide, esisebenza ngakumbi ekuphatheni uhlobo lwe-2 yeswekile.

Ukusebenza kwezinto eziphilayo

I-Semaglutide (i-Rybelsus, i-Ozempic, i-NN9535, i-OG217SC, i-NNC0113-0217) i-glucagon-efana ne-peptide ye-1 (GLP-1) i-analog, i-agonist ye-GLP-1receptor, kunye nohlobo olunokubakho lwe-2 I-Therapeutic efficacy (T2DM mellitus) yesifo sikashukela.

Inkqubo yoMgangatho

Ngokubanzi, inkqubo yomgangatho kunye nesiqinisekiso sikhoyo sibandakanya onke amanqanaba okuveliswa kwemveliso egqityiweyo. Imisebenzi eyaneleyo yokwenziwa kwemveliso nolawulo iyenziwa ngokuhambelana neenkqubo/inkcukacha ezivunyiweyo. Ulawulo lotshintsho kunye nenkqubo yokuphatha ukutenxa ikhona, kwaye uvavanyo lwempembelelo oluyimfuneko kunye nophando lwenziwa. Iinkqubo ezifanelekileyo zikhona ukuqinisekisa umgangatho wemveliso ngaphambi kokuba ikhululwe kwimarike.


  • Ngaphambili:
  • Okulandelayo:

  • Bhala umyalezo wakho apha kwaye uwuthumele kuthi